文献速递骨质疏松与代谢性骨病

微压痕技术研究1型糖尿病患者骨材料特性

The use of microindentation for the study of bone properties in type 1 diabetes mellitus patients.
PubMed 文献 · Osteoporos Int · 2019-10-23

本文通过横断面研究,采用微压痕技术评估45例绝经前1型糖尿病女性与21例健康对照的骨材料强度指数(BMSi)和骨密度(BMD),发现两组间BMSi和BMD均无差异;在T1DM患者中,代谢综合征特征数量或微血管病变的存在与BMSi无关。结论提示绝经前T1DM患者骨组织特性与对照组相当,建议进一步扩大规模研究确认。

要点

  • 绝经前1型糖尿病女性与健康对照的BMSi和BMD均无差异。
  • T1DM患者平均HbA1c为7.52%±1.00%,平均病程22.6±12.2年。
  • 代谢综合征特征数量或微血管病变与BMSi无关联。

核心结论

  • 绝经前1型糖尿病患者的骨组织特性与健康对照相当,提示强化胰岛素治疗可能保护骨骼健康。

研究设计与样本

  • 横断面研究,纳入45例绝经前1型糖尿病女性和21例健康对照,按年龄和BMI匹配,采用微压痕技术评估BMSi,并测量BMD。

主要发现

  • T1DM患者与健康对照之间BMSi无差异,BMD也无差异。
  • T1DM患者平均HbA1c为7.52%±1.00%,平均糖尿病病程为22.6±12.2年。
  • 8例(17.7%)T1DM患者符合代谢综合征(MetS)标准,12例(26.7%)存在微血管并发症。
  • 代谢综合征特征数量或微血管病变的存在均与BMSi无关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Diabetes mellitus is associated with a higher risk of fracture. In this study, we analysed the bone quality of premenopausal women with type 1 diabetes mellitus by microindentation. No differences in bone quality were identified between patients and healthy controls, suggesting that intensive insulin therapy can preserve bone health. PURPOSE: To compare the bone quality of women with type 1 diabetes mellitus (T1DM) and healthy controls, and to determine the relationship with bone mineral density (BMD). METHODS: This was a cross-sectional study of 45 premenopausal women with T1DM and 21 healthy controls, matched according to age and BMI. Clinical parameters, BMD and bone tissue mechanical properties (assessed using the bone material strength index [BMSi]) were evaluated in each group using microindentation. In T1DM patients, glycosylated haemoglobin (HbA1c), the number of hypoglycaemic events and the status of chronic complications were also analysed. RESULTS: No differences in BMSi or BMD between T1DM patients and healthy controls were identified. In the T1DM patients, the mean HbA1c was 7.52% ± 1.00% and the mean time elapsed since diagnosis was 22.6 ± 12.2 years. Eight patients (17.7%) met the criteria for metabolic syndrome (MetS), and microvascular complications were present in 12 patients (26.7%). Neither the number of features of MetS present nor the presence of microangiopathy was found to be associated with BMSi. CONCLUSIONS: T1DM premenopausal patients showed bone tissue properties comparable to those shown by controls. Further larger-scale studies should be conducted to confirm these results.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Ballesta S, Güerri-Fernández RC, Chillarón JJ, et al. The use of microindentation for the study of bone properties in type 1 diabetes mellitus patients. Osteoporos Int. 2019. PMID: 31641800. doi:10.1007/s00198-019-05178-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。